Aspirin News and Research RSS Feed - Aspirin News and Research

Aspirin also known as acetylsalicylic acid is a salicylate drug, often used as an analgesic to relieve minor aches and pains, as an antipyretic to reduce fever, and as an anti-inflammatory medication. Aspirin also has an antiplatelet, or "anti-clotting", effect and is used in long-term, low doses to prevent heart attacks, strokes and blood clot formation in people at high risk for developing blood clots. It has also been established that low doses of aspirin may be given immediately after a heart attack to reduce the risk of another heart attack or of the death of cardiac tissue.
Omega-3 PUFA biomarkers demonstrate benefits for fatal CHD

Omega-3 PUFA biomarkers demonstrate benefits for fatal CHD

Regular consumption of seafood and plant-based omega-3 polyunsaturated fatty acids could help lower the risk of fatal coronary heart disease, confirm findings from a pooled analysis of 19 studies. [More]
New study reveals startling trend in mortality rates from heart disease and stroke

New study reveals startling trend in mortality rates from heart disease and stroke

After more than a decade of steady improvements, the decline in mortality rates from heart disease and stroke has slowed nationally and nearly leveled out since 2011, according to a new analysis from Kaiser Permanente published in JAMA Cardiology. [More]
Blood levels of omega-3s fatty acids linked to lower risk of deadly heart attacks

Blood levels of omega-3s fatty acids linked to lower risk of deadly heart attacks

Blood levels of seafood and plant-based omega-3 fatty acids are moderately associated with a lower risk of dying from heart attacks, according to a new epidemiological study, published today in JAMA Internal Medicine, led by Liana C. Del Gobbo, Ph.D., a postdoctoral research fellow in the division of cardiovascular medicine at Stanford University School of Medicine and senior author Dariush Mozaffarian, M.D., Dr.P.H., dean of the Friedman School of Nutrition Science and Policy at Tufts University in Boston. [More]
CYP2C19 gene variants undermine clopidogrel stroke prevention

CYP2C19 gene variants undermine clopidogrel stroke prevention

The first look at CYP2C19 mutations in the context of a randomised controlled trial has confirmed suspicions that they affect the efficacy of clopidogrel in patients with acute stroke. [More]
New Aspirin-Guide mobile app helps clinicians and patients make informed decisions about aspirin use

New Aspirin-Guide mobile app helps clinicians and patients make informed decisions about aspirin use

Low dose aspirin is recommended by clinicians as a preventive measure for patients who have already had a heart attack or stroke, but the risk of taking low-dose aspirin to prevent or delay a first heart attack or stroke is less clear, as the benefit for reducing the risk of cardiovascular disease (CVD) must be balanced with the increased risk of gastrointestinal or other bleeding. [More]
AF patients at risk for stroke mostly treated with aspirin-only prescription instead of blood thinners

AF patients at risk for stroke mostly treated with aspirin-only prescription instead of blood thinners

Researchers at University of California San Diego School of Medicine and University of California, San Francisco School of Medicine report that more than 1 in 3 atrial fibrillation (AF) patients at intermediate to high risk for stroke are treated with aspirin alone, despite previous data showing this therapy to be inferior to blood thinners. [More]
Caribbean, African-born women more likely to be admitted at ICU during delivery

Caribbean, African-born women more likely to be admitted at ICU during delivery

Women born in the Caribbean or Africa are two times more likely to be admitted to an intensive care unit at the time of their delivery than Canadian-born women, a new study has found. [More]
CHD rates decrease significantly in the U.S.

CHD rates decrease significantly in the U.S.

Significant improvements seen across multiple sociodemographic groups, according to a new study in the American Journal of Preventive Medicine [More]
NCMC develops national roadmap for large-scale manufacturing of cell-based therapeutics

NCMC develops national roadmap for large-scale manufacturing of cell-based therapeutics

An industry-driven consortium has developed a national roadmap designed to chart the path to large-scale manufacturing of cell-based therapeutics for use in a broad range of illnesses including cancer, neuro-degenerative diseases, blood and vision disorders and organ regeneration and repair. [More]
Screening PSA levels in younger men could accurately predict future risk of prostate cancer

Screening PSA levels in younger men could accurately predict future risk of prostate cancer

Prostate cancer screening with prostate-specific antigen (PSA) has been shown to reduce death and the spread of prostate cancer to other parts of the body, but the PSA test remains highly controversial as it frequently leads to over diagnosis and over treatment of men who may not be at risk. [More]
Aspirin may increase likelihood of surviving colon cancer

Aspirin may increase likelihood of surviving colon cancer

It is well known that the drug ASA, also known internationally as Aspirin, has analgesic and fever-reducing properties. However, this drug may also increase the likelihood of surviving colon cancer. [More]
Neutral atherosclerosis trial highlights effectiveness of optimal medical therapy

Neutral atherosclerosis trial highlights effectiveness of optimal medical therapy

Salsalate has no greater effect than placebo on the progression of coronary artery plaque, show the findings of the randomised TINSAL-CVD trial. [More]
Just one stroke risk factor signals anticoagulation need in AF

Just one stroke risk factor signals anticoagulation need in AF

The risk of stroke or systemic embolism is significantly increased in atrial fibrillation patients with just one risk factor apart from gender, say researchers. [More]
Migraine increases vascular disease risk in women

Migraine increases vascular disease risk in women

Women with migraine have a 50% increased risk of major cardiovascular disease, suggests a cohort study of Nurses' Health Study II participants. [More]
Vital compound in common anti-inflammatory drugs can combat cancer, inflammation

Vital compound in common anti-inflammatory drugs can combat cancer, inflammation

Scientists from the Gladstone Institutes have identified a new pathway by which salicylic acid--a key compound in the nonsteroidal anti-inflammatory drugs aspirin and diflunisal--stops inflammation and cancer. [More]
UTHealth's Mobile Stroke Unit fights stroke through research, technology and patient care

UTHealth's Mobile Stroke Unit fights stroke through research, technology and patient care

About 800,000 strokes occur in America each year; that's about one every 40 seconds. Houston resident Joe Carrabba experienced one of them. [More]
CKD status does not affect health status outcomes after AMI

CKD status does not affect health status outcomes after AMI

Chronic kidney disease does not accentuate the decline in health status often experienced by patients after acute myocardial infarction, US study data show. [More]
Bone marrow transplantation dose may have lasting effects on HSC behavior

Bone marrow transplantation dose may have lasting effects on HSC behavior

Unlike aspirin, bone marrow doesn't come with a neatly printed label with dosage instructions. However, a new study published in Cell Reports provides clues about how the dose of transplanted bone marrow might affect patients undergoing this risky procedure, frequently used to treat cancer and blood diseases. [More]
Early aspirin benefits after minor stroke 'underestimated'

Early aspirin benefits after minor stroke 'underestimated'

A meta-analysis of individual patient data has thrown light on the benefits of aspirin for secondary prevention in patients with ischaemic stroke. [More]
Mini-stroke should immediately be treated with aspirin, recommend researchers

Mini-stroke should immediately be treated with aspirin, recommend researchers

Taking aspirin immediately after experiencing stroke-like symptoms could significantly reduce the risk of a major stroke occurring in the next few days, according to a study published in The Lancet. [More]
Advertisement
Advertisement